Empagliflozin, a sodium‐glucose cotransporter inhibitor enhancing mitochondrial action and cardioprotection in metabolic syndrome
Article in Journal of Cellular Physiology (May 2024)
The most recent citing publications are shown below. View all 63 publications that cite this research output on Dimensions.
Article in Journal of Cellular Physiology (May 2024)
Article in Cardiovascular Research (May 2024)
Article in Frontiers in Pharmacology (April 2024)